Research location
Verdun
Quebec, Canada
Advertisement
Research activity in Verdun
Quebec, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 44 trials and 44 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Verdun
44 linked trials · page 1 of 1Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for PsychosisNCT07786714 · 2026-08-01 · 1 site observation
RECRUITING
Accelerated Neuromodulation Therapy for Negative Symptoms of SchizophreniaNCT07428460 · 2026-02-01 · 1 site observation
RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT05552157 · 2024-11-22 · 1 site observation
RECRUITING
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT06647498 · 2024-11-22 · 1 site observation
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)NCT06126224 · 2023-08-28 · 1 site observation
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)NCT05980949 · 2023-07-11 · 1 site observation
RECRUITING
Dominantly Inherited Alzheimer Network (DIAN)NCT00869817 · 2009-01-01 · 1 site observation
RECRUITING
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)NCT05269394 · 2021-12-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Social Skills and Emotion Regulation Training "SSERT" for Trauma in PsychosisNCT05100875 · 2021-07-01 · 1 site observation
COMPLETED
A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's DiseaseNCT04520412 · 2020-10-27 · 1 site observation
SUSPENDED
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaNCT02783573 · 2016-07-01 · 1 site observation
TERMINATED
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseNCT02484547 · 2015-09-15 · 1 site observation
TERMINATED
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseNCT02477800 · 2015-08-13 · 1 site observation
TERMINATED
Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode PsychosisNCT02294409 · 2014-10-01 · 1 site observation
COMPLETED
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)NCT02245568 · 2014-08-01 · 1 site observation
TERMINATED
A Study of Gantenerumab in Participants With Mild Alzheimer DiseaseNCT02051608 · 2014-03-27 · 1 site observation
COMPLETED
A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseNCT01767311 · 2012-12-20 · 1 site observation
COMPLETED
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With CrenezumabNCT01723826 · 2012-12-07 · 1 site observation
COMPLETED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001NCT01760005 · 2012-12-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.NCT04623242 · 2012-12-01 · 1 site observation
COMPLETED
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease TherapyNCT01677754 · 2012-10-24 · 1 site observation
COMPLETED
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentNCT01457677 · 2011-12-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)NCT01343966 · 2011-04-30 · 1 site observation
COMPLETED
An Non-Interventional Study of Patients With Persistent Symptoms of SchizophreniaNCT01634542 · 2011-02-01 · 1 site observation
COMPLETED
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)NCT01192906 · 2010-12-01 · 1 site observation
COMPLETED
A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's DiseaseNCT00937352 · 2009-07-01 · 1 site observation
TERMINATED
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's DiseaseNCT00884507 · 2009-05-01 · 1 site observation
COMPLETED
Canadian Study of Trandolapril on Blood Pressure in Hypertensive PatientsNCT01078584 · 2008-12-01 · 1 site observation
COMPLETED
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeNCT00748566 · 2008-12-01 · 1 site observation
TERMINATED
Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With PlaceboNCT00762411 · 2008-09-01 · 1 site observation
COMPLETED
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With SchizophreniaNCT00640601 · 2008-03-01 · 1 site observation
COMPLETED
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)NCT00574132 · 2007-12-01 · 1 site observation
COMPLETED
Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's DiseaseNCT00501111 · 2007-07-01 · 1 site observation
COMPLETED
Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer'sNCT00322036 · 2006-05-01 · 1 site observation
TERMINATED
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early PsychosisNCT00246259 · 2004-10-01 · 1 site observation
COMPLETED
Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's DiseaseNCT00857233 · 2004-06-01 · 1 site observation
TERMINATED
An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of GalantamineNCT00297414 · 2004-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's DiseaseNCT00857649 · 2003-12-01 · 1 site observation
TERMINATED
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeNCT00103649 · 2003-11-01 · 1 site observation
COMPLETED
Maternal Adversity, Vulnerability and NeurodevelopmentNCT03434457 · 2003-10-01 · 1 site observation
COMPLETED
Seroquel STACK Study in Schizophrenic or Schizoaffective SubjectsNCT00328978 · 2003-10-01 · 1 site observation
COMPLETED
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.NCT00151502 · 2002-11-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseNCT00040404 · 2002-03-01 · 1 site observation
TERMINATED
Memory Impairment Study (Mild Cognitive Impairment Study)NCT00000173 · 1999-03-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.